On February 27, 2023, DENTSPLY SIRONA Inc. announced that Richard Rosenzweig has been appointed Senior Vice President, Corporate Development, General Counsel and Secretary. With a 25-year history advising global health care companies, Mr. Rosenzweig joins most recently from AngioDynamics where he led the legal department, including compliance, and served as Secretary to the Board as Senior Vice President, General Counsel & Secretary.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.2 USD | +1.40% | -0.63% | -20.76% |
May. 03 | Evercore ISI Adjusts Dentsply Sirona Price Target to $35 From $40, Maintains Outperform Rating | MT |
May. 03 | UBS Adjusts Price Target on Dentsply Sirona to $37 From $38, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.76% | 5.77B | |
-4.91% | 183B | |
+0.46% | 108B | |
-3.62% | 67.51B | |
+3.26% | 50.67B | |
+9.11% | 44.7B | |
+2.41% | 40.95B | |
+6.39% | 26.8B | |
+3.83% | 26.71B | |
+12.66% | 24.62B |
- Stock Market
- Equities
- XRAY Stock
- News DENTSPLY SIRONA Inc.
- DENTSPLY SIRONA Inc. Appoints Richard Rosenzweig as Senior Vice President, Corporate Development, General Counsel and Secretary